ATLAS / Macro Radar / Reporting / LRMR

Larimar Therapeutics, Inc. (LRMR) reporting calendar

Larimar Therapeutics, Inc. files periodic reports with the SEC as LRMR on Nasdaq. Atlas tracks 48 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
15 Jul 2026 – 5 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
14 May 2026
Reports on record
48

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 41 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open LRMR market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202614 May 202644 days0001193125-26-224087
10-K31 Dec 202519 Mar 202678 days0001193125-26-115878
10-Q30 Sep 20255 Nov 202536 days0001193125-25-266969
10-Q30 Jun 202514 Aug 202545 days0000950170-25-108797
10-Q31 Mar 202530 Apr 202530 days0000950170-25-061222
10-K31 Dec 202424 Mar 202583 days0000950170-25-043925
10-Q30 Sep 202430 Oct 202430 days0000950170-24-119100
10-Q30 Jun 20248 Aug 202439 days0000950170-24-093733
10-Q31 Mar 20249 May 202439 days0000950170-24-056965
10-K31 Dec 202314 Mar 202474 days0000950170-24-031529
10-Q30 Sep 202314 Nov 202345 days0000950170-23-063517
10-Q30 Jun 202310 Aug 202341 days0000950170-23-041293
10-Q31 Mar 202315 May 202345 days0000950170-23-022187
10-K31 Dec 202214 Mar 202373 days0000950170-23-007855
10-Q30 Sep 202210 Nov 202241 days0000950170-22-024223
10-Q30 Jun 202211 Aug 202242 days0000950170-22-016917
10-Q31 Mar 202212 May 202242 days0000950170-22-009590
10-K31 Dec 202125 Mar 202284 days0000950170-22-004637
10-Q30 Sep 202112 Nov 202143 days0000950170-21-004331
10-Q30 Jun 202112 Aug 202143 days0001564590-21-043701
10-Q31 Mar 202110 May 202140 days0001564590-21-026084
10-K31 Dec 20204 Mar 202163 days0001564590-21-011003
10-Q30 Sep 202012 Nov 202043 days0001564590-20-053618
10-Q30 Jun 202014 Aug 202045 days0001564590-20-040314
10-Q31 Mar 20207 May 202037 days0001564590-20-022942
10-K31 Dec 20195 Mar 202065 days0001564590-20-008984
10-Q30 Sep 20196 Nov 201937 days0001564590-19-041090
10-Q30 Jun 20198 Aug 201939 days0001564590-19-030904
10-Q31 Mar 20199 May 201939 days0001564590-19-018086
10-K31 Dec 201814 Mar 201973 days0001564590-19-007863
10-Q30 Sep 20189 Nov 201840 days0001564590-18-028944
10-Q30 Jun 20189 Aug 201840 days0001193125-18-244422
10-Q31 Mar 201810 May 201840 days0001193125-18-159281
10-K31 Dec 20179 Mar 201868 days0001193125-18-077456
10-Q30 Sep 20177 Nov 201738 days0001193125-17-335910
10-Q30 Jun 20179 Aug 201740 days0001193125-17-252840
10-Q31 Mar 20179 May 201739 days0001193125-17-164257
10-K31 Dec 201610 Mar 201769 days0001193125-17-078784
10-Q30 Sep 20169 Nov 201640 days0001193125-16-764420
10-Q30 Jun 20165 Aug 201636 days0001193125-16-672131

Source: SEC EDGAR company submissions for CIK 0001374690. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.